KMUP-1 inhibits hypertension-induced left ventricular hypertrophy through regulation of nitric oxide synthases, ERK1/2, and calcineurin

Kaohsiung Journal of Medical Sciences

Volumn 28, Issue 11, 2012, Pages 567-576

  Yeh, Jwu Lai ^a   Liu, Chung Pin ^b   Hsu, Jong Hau ^a,c   Tseng, Ching Jiunn ^d   Wu, Ping Ju ^a   Wang, Yi Ya ^a   Wu, Jiunn Ren ^a,c   Chen, Ing Jun ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b YUAN'S GENERAL HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Calcineurin A; Cardiac hypertrophy; Extracellular signal regulated kinase; Hypertension; Nitric oxide synthase

Indexed keywords

CALCINEURIN; KMUP 1; MITOGEN ACTIVATED PROTEIN KINASE 1; NITRIC OXIDE SYNTHASE; SILDENAFIL; UNCLASSIFIED DRUG; XANTHINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME REGULATION; HEART LEFT VENTRICLE HYPERTROPHY; HYPERTENSION; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SURVIVAL;

ANIMALS; CALCINEURIN; HYPERTROPHY, LEFT VENTRICULAR; MALE; MAP KINASE SIGNALING SYSTEM; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PIPERIDINES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; XANTHINES;

EID: 84868662656     PISSN: 1607551X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.kjms.2012.04.022     Document Type: Article

References (27)

1. K. Berenji, M.H. Drazner, B.A. Rothermel, and J.A. Hill Does load-induced ventricular hypertrophy progress to systolic heart failure? Am J Physiol Heart Circ Physiol 289 2005 H8 16
2. A.Y. Chong, A.D. Blann, J. Patel, B. Freestone, E. Hughes, and G.Y. Lip Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide Circulation 110 2004 1794 1798
3. N. Kobayashi, T. Ohno, K. Yoshida, H. Fukushima, Y. Mamada, and M. Nomura Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats Am J Hypertens 21 2008 576 581
4. A. Podlutsky, P. Ballabh, and A. Csiszar Oxidative stress and endothelial dysfunction in vascular disease Am J Physiol Heart Circ Physiol 298 2010 H346 H351
5. F. Han, Y.M. Lu, H. Hasegawa, H. Kanai, E. Hachimura, and Y. Shirasaki Inhibition of dystrophin breakdown and endothelial nitric oxide synthase uncoupling accounts for cytoprotection by 3-[2-[4-(3-Chloro-2-methylphenyl)-1- piperazinyl]ethyl]-5,6-dimethoxy-1- (4-imidazolylmethyl)-1H-indazole Dihydrochloride 3.5 Hydrate (DY-9760e) in left ventricular hypertrophied mice J Pharmacol Exp Ther 332 2010 421 428
6. E. Takimoto, H.C. Champion, M. Li, D. Belardi, S. Ren, and E.R. Rodriguez Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy Nat Med 11 2005 214 222
7. H. Senzaki, C.J. Smith, G.J. Juang, T. Isoda, S.P. Mayer, and A. Ohler Cardiac phosphodiesterase 5 (cGMP-specific) modulates β-adrenergic signaling in vivo and is down-regulated in heart failure FASEB J 15 2001 1718 1726
8. R.C. Kukreja Cardiovascular protection with sildenafil following chronic inhibition of nitric oxide synthase Br J Pharmacol 150 2007 538 540
9. F.N. Salloum, A. Abbate, A. Das, J.E. Houser, C.A. Mudrick, and I.Z. Qureshi Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice Am J Physiol Heart Circ Physiol 294 2008 H1398 H1406
10. J.W. Ramos The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells Int J Biochem Cell Biol 40 2008 2707 2719
11. A. Das, L. Xi, and R.C. Kukreja Protein kinase G-dependent cardioprotective mechanism of phosphodiesterase-5 inhibition involves phosphorylation of ERK and GSK3beta J Biol Chem 283 2008 29572 29585
12. B.N. Wu, H.F. Tu, D.G. Welsh, and I.J. Chen KMUP-1 activates BKCa channels in basilar artery myocytes via cyclic nucleotide-dependent protein kinases Br J Pharmacol 146 2005 862 871
13. B.N. Wu, C.W. Chen, S.F. Liou, J.L. Yeh, H.H. Chung, and I.J. Chen Inhibition of proinflammatory tumor necrosis factor-α-induced inducible nitric-oxide synthase by xanthine-based 7-[2-[4-(2- chlorobenzene) piperazinyl]ethyl]-1,3- dimethyl xanthine (KMUP-1) and 7-[2-[4-(4-nitrobenzene) piperazinyl] ethyl]-1, 3-dimethylxanthine (KMUP-3) in rat trachea: the involvement of soluble guanylate cyclase and protein kinase G Mol Pharmacol 70 2006 977 985
14. H.H. Chung, Z.K. Dai, B.N. Wu, J.L. Yeh, C.Y. Chai, and K.S. Chu KMUP-1 inhibits acute and chronic pulmonary artery hypertension via eNOS-enhancement and cGMP-dependent inhibition of RhoA/Rho Kinase Br J Pharmacol 160 2010 971 986
15. J.L. Yeh, J.H. Hsu, P.J. Wu, S.F. Liou, C.P. Liu, and I.J. Chen KMUP-1 attenuates isoprenaline-induced cardiac hypertrophy in rats through NO/cGMP/PKG and ERK1/2/calcineurin A pathways Br J Pharmacol 159 2010 1151 1160
16. H. Ruetten, S. Dimmeler, D. Gehring, C. Ihling, and A.M. Zeiher Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload Cardiovasc Res 66 2005 444 453
17. I.N. Mungrue, R. Gros, X. You, A. Pirani, A. Azad, and T. Csont Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death J Clin Invest 109 2002 735 743
18. G.W. Booz Putting the brake on cardiac hypertrophy: exploiting the NO-cGMP counter-regulatory system Hypertension 45 2005 341 346
19. M. Khairallah, R.J. Khairallah, M.E. Young, B.G. Allen, M.A. Gillis, and G. Danialou Sildenafil and cardiomyocyte-specific cGMP signaling prevent cardiomyopathic changes associated with dystrophin deficiency Proc Natl Acad Sci U S A 105 2008 7028 7033
20. J.S. Beckman, and W.H. Koppenol Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly Am J Physiol 271 1996 C1424 C1437
21. E. Milani, S. Nikfar, R. Khorasani, M.J. Zamani, and M. Abdollahi Reduction of diabetes-induced oxidative stress by phosphodiesterase inhibitors in rats Comp Biochem Physiol C Toxicol Pharmacol 140 2005 251 255
22. H. Zhang, Y. Park, J. Wu, X. Chen, S. Lee, and J. Yang Role of TNF-alpha in vascular dysfunction Clin Sci 116 2009 219 230
23. P.B. Massion, M. Pelat, C. Belge, and J.L. Balligand Regulation of the mammalian heart function by nitric oxide Comp Biochem Physiol A Mol Integr Physiol 142 2005 144 150
24. O.F. Bueno, and J.D. Molkentin Involvement of extracellular signal regulated kinases 1/2 in cardiac hypertrophy and cell death Circ Res 91 2002 776 781
25. K. Obasanjo-Blackshire, R. Mesquita, R.I. Jabr, J.D. Molkentin, S.L. Hart, and M.S. Marber Calcineurin regulates NFAT-dependent iNOS expression and protection of cardiomyocytes: co-operation with Src tyrosine kinase Cardiovasc Res 71 2006 672 683
26. 2+-calcineurin-NFAT cascade in cardiac myocytes Cardiovasc Res 63 2004 450 457
27. G. Rossoni, B. Manfredi, V.De G. Colonna, M. Berti, M. Guazzi, and F. Berti Sildenafil reduces L-NAME-induced severe hypertension and worsening of myocardial ischaemia-reperfusion damage in the rat Br J Pharmacol 150 2007 567 576